BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26232069)

  • 41. Anaplastic large cell lymphoma associated with a breast implant capsule: a case report and review of the literature.
    Wong AK; Lopategui J; Clancy S; Kulber D; Bose S
    Am J Surg Pathol; 2008 Aug; 32(8):1265-8. PubMed ID: 18594466
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PIP implant biodurability: a post-publicity update.
    Berry MG; Stanek JJ
    J Plast Reconstr Aesthet Surg; 2013 Sep; 66(9):1174-81. PubMed ID: 23668948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Poly Implant Prothèse (PIP) incidence of device failure and capsular contracture: a retrospective comparative analysis.
    Khan UD
    Aesthetic Plast Surg; 2013 Oct; 37(5):906-13. PubMed ID: 23860815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Implant-associated primary anaplastic large-cell lymphoma with simultaneous involvement of bilateral breast capsules.
    Bautista-Quach MA; Nademanee A; Weisenburger DD; Chen W; Kim YS
    Clin Breast Cancer; 2013 Dec; 13(6):492-5. PubMed ID: 24267734
    [No Abstract]   [Full Text] [Related]  

  • 45. Bilateral supraclavicular swelling: an unusual presentation of ruptured Poly Implant Prosthese (PIP) breast implants.
    Manickavasagar T; Morritt AN; Offer GJ
    J Plast Reconstr Aesthet Surg; 2013 Feb; 66(2):267-9. PubMed ID: 22836112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemotherapy-resistant breast implant-associated anaplastic large cell lymphoma.
    Parthasarathy M; Orrell J; Mortimer C; Ball L
    BMJ Case Rep; 2013 Nov; 2013():. PubMed ID: 24285813
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
    Clemens MW; Medeiros LJ; Butler CE; Hunt KK; Fanale MA; Horwitz S; Weisenburger DD; Liu J; Morgan EA; Kanagal-Shamanna R; Parkash V; Ning J; Sohani AR; Ferry JA; Mehta-Shah N; Dogan A; Liu H; Thormann N; Di Napoli A; Lade S; Piccolini J; Reyes R; Williams T; McCarthy CM; Hanson SE; Nastoupil LJ; Gaur R; Oki Y; Young KH; Miranda RN
    J Clin Oncol; 2016 Jan; 34(2):160-8. PubMed ID: 26628470
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of local complications following explantation of silicone breast implants.
    Siggelkow W; Klosterhalfen B; Klinge U; Rath W; Faridi A
    Breast; 2004 Apr; 13(2):122-8. PubMed ID: 15019692
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extranodal NK/T-cell lymphoma, nasal type, arising in association with saline breast implant: expanding the spectrum of breast implant-associated lymphomas.
    Aladily TN; Nathwani BN; Miranda RN; Kansal R; Yin CC; Protzel R; Takowsky GS; Medeiros LJ
    Am J Surg Pathol; 2012 Nov; 36(11):1729-34. PubMed ID: 23073330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recall management of patients with Rofil Medical breast implants.
    Schott S; Bruckner T; Golatta M; Wallwiener M; Küffner L; Mayer C; Paringer C; Domschke C; Blumenstein M; Schütz F; Sohn C; Heil J
    J Plast Reconstr Aesthet Surg; 2014 Jul; 67(7):939-45. PubMed ID: 24785684
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk of Anaplastic Large-Cell Lymphoma (ALCL) in Cases of Late Seroma Formation After Breast Implant Insertion.
    Hwang K; Kim H; Kim HM; Kim JH
    Eplasty; 2021; 21():e4. PubMed ID: 33747338
    [No Abstract]   [Full Text] [Related]  

  • 52. ALK-1-negative anaplastic large cell lymphoma associated with breast implants: a new clinical entity.
    Lazzeri D; Agostini T; Bocci G; Giannotti G; Fanelli G; Naccarato AG; Danesi R; Tuccori M; Pantaloni M; D'Aniello C
    Clin Breast Cancer; 2011 Oct; 11(5):283-96. PubMed ID: 21729665
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The "PIP problem": clinical and histologic characteristics.
    Correia-Sá I; Rodrigues-Pereira P; Marques M
    Aesthetic Plast Surg; 2013 Oct; 37(5):936-40. PubMed ID: 23943050
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Breast implants and anaplastic large cell lymphoma: What do we know?].
    Mychaluk J; Perignon D; Qassemyar Q; Gianfermi M; Sinna R
    Ann Chir Plast Esthet; 2012 Feb; 57(1):1-8. PubMed ID: 22243720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Importance of histological analysis of seroma fluid.
    Murphy S; Carroll S
    Aesthetic Plast Surg; 2013 Feb; 37(1):187-8. PubMed ID: 23288102
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [PIP breast implants: a series of 217 explants].
    Tropet Y; Oulharj S; Pauchot J
    Bull Acad Natl Med; 2013 Jan; 197(1):123-30; discussion 130-1. PubMed ID: 24672984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biodurability of Poly Implant Prothèse (PIP) breast implants: A prospective analysis of 1028 prostheses in 514 patients.
    Thomson RM; Healy SE; Haj Basheer M; Morris K; Whitaker IS
    J Plast Reconstr Aesthet Surg; 2018 Jun; 71(6):953-955. PubMed ID: 29685840
    [No Abstract]   [Full Text] [Related]  

  • 58. Ruptured poly-implant protheses breast implant after aesthetic breast augmentation: diagnosis, case management, and histologic evaluation.
    Dieterich M; Stubert J; Stachs A; Radke A; Reimer T; Gerber B
    Aesthetic Plast Surg; 2013 Feb; 37(1):91-4. PubMed ID: 23288097
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Breast Implant-Associated Bilateral B-Cell Lymphoma.
    Chen VW; Hoang D; Clancy S
    Aesthet Surg J; 2020 Jan; 40(2):NP52-NP58. PubMed ID: 29635460
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PIP silicone breast implants: rupture rates based on the explantation of 676 implants in a single surgeon series.
    Quaba O; Quaba A
    J Plast Reconstr Aesthet Surg; 2013 Sep; 66(9):1182-7. PubMed ID: 23725742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.